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The Costs of Managing Lower Limb-threatening Ischaemia 
S. Singh, L. Evans, D. Datta, P. Gaines and J. D. Beard* 
Sheffield Vascular Institute, Northern General Hospital, Sheffield, U.K. 
One hundred and fifty consecutive patients presenting with limb-threatening ischaemia were studied prospectively to 
determine treatment and rehabilitation costs in the first year. Limb salvage was attempted in 104 (69%) patients but failed 
in 13%. Mortality at 1 year was 27%. The cost of treatment, inpatient stay, occupational therapy, physiotherapy, 
convalescence, disablement services, home adaptations, home care, district nursing, transportation and outpatient visits 
were determined for each patient. The patients were classified according to their presentation and initial treatment into flve 
groups (number of patients) whose median management costs (interquartile range) for 12 months were: 
Gp 1 (23) - Revascularisation for acute ischaemia = £3970 (2984 - 5511) 
Gp 2 (29) - Angioplasty for critical ischaemia = £6611 (3630 - 10200) 
Gp 3 (52) - Reconstruction for critical ischaemia = £6766 (4337 - 9677) 
Gp 4 (34) - Primary amputation = £10162 (7894 - 13026) 
Gp 5 (12) - Primary bilateral amputations = £13848 (11440 - 18056) 
At 1 year, there was no significant difference in the cost of managing a patient with a critically ischaemic limb by 
angioplasty or surgical reconstruction. The cost of revascularisation for acute ischaemia was comparatively ow because 
these patients required minimal rehabilitation. The median cost of managing a patient following amputation was almost 
twice that of successful limb salvage justifying an aggressive revascularisation policy. However, justification of such a 
policy on economic grounds requires salvage failure episodes to be minimised as they increase costs considerably. 
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Introduction 
An aggressive policy of revascularisation i limb- 
threatening (critical ischaemia) can reduce amputation 
rates ~-3 and such a policy is economically sound. 4'5 
However, episodes of failed revascularisation increase 
costs considerably 6 whilst evidence suggests that 
revascularisation by angioplasty results in shorter 
inpatient stay 7 and is thus more cost-effective. 
This study prospectively evaluated the costs of 
managing both acute and chronic limb-threatening 
ischaemia according to the treatment initiated at 
presentation. 
Patients and Methods 
Over a 3 year period, 150 consecutive patients present- 
ing with limb-threatening ischaemia were prospec- 
tively entered into this study and followed-up for a 
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year. Limb-threatening ischaemia was defined in 
chronically ischaemic limbs as the presence of rest 
pain and an ankle-brachial pressure index (ABI) of < 
0.5 whilst in acutely ischaemic limbs, the presence of a 
sensorimotor deficit and absent Doppler signals at the 
ankle were required. Limb salvage was attempted in 
104 (69.3%) of these patients. 
The cost over a period of 12 months of treatment, 
inpatient stay, occupational therap)~ physiotherapy, 
disablement services, convalescence, home adapta- 
tions, home care, district nursing, transportation and 
outpatient visits were determined for each patient. 
Treatment costs included those of radiology, theatre 
and consumable usage. Inpatient stay, occupational 
therapy, physiotherapj6 disablement services (includ- 
ing wheelchair and prosthetic osts), convalescence 
and outpatient visit costs were calculated for each 
patient based on estimates of cost per unit time for 
these facilities (including depreciation costs) obtained 
from the Department of Corporate Planning, Royal 
Hallamshire Hospital. The cost of home adaptations 
and home care were obtained for individual patients 
from Sheffield Family and Community Services. 
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Transportation costs were provided by South York- 
shire Ambulance Service. Further details of costings 
are provided in Table 1. 
For the purposes of analysis, patients were grouped 
according to their presentation and the treatment they 
initially received. Group 1 included all patients pre- 
senting with an acutely ischaemic limb who under- 
went attempted revascularisation. Groups 2, 3 and 4 
comprised patients with critically ischaemic limbs 
who underwent initial treatment in the form of 
angioplasty, surgical reconstruction and amputation 
respectively. Patients undergoing bilateral amputation 
or amputation of a second limb were grouped (group 
5) separately because of their greater rehabilitation 
needs. In analysing the median costs for each treat- 
ment group, we included the costs associated with 
episodes of failed revascularisation. The costs of this 
sub-group of patients in whom revascularisation 
failed were also analysed separately. Table 2 shows the 
median age, ratio of males to females and proportion 
of diabetics in each group. Patients who underwent 
primary amputation were younger than those in 
whom limb salvage was attempted (MW;Z=- 
2.465;p = 0.0136). There was also a greater proportion 
of males (Chi-squared =6.496;df = 1;p = 0.011) and 
Table 1. Costings 
Inpatient Cost/£ 
Surgical bed/per day 
ITU/HDU bed/per day 
Theatre usage*/per hour 
Arteriogram*/Angioplasty 
Physiotherapy/per hour 
Occupational therapy/per hour 
Convalescence / p r week 
124.74 
1000.00 
250.00 
480.00 
11.00 
13.00 
340.00 
Outpatient 
Clinic - 
First visit 72.00 
Follow-up visit 34.00 
Transport/per journey 4.80 
District nursing/per visit 25.00 
Home care/per hour 5.00 
*Does not indude cost of consumables. 
Table 2. Patient details 
diabetics (Chi-squared -- 7.025;df = df = 1;p = 0.008) 
amongst hose who underwent primary amputation. 
Statistical analysis 
Statistical comparisons between groups were made 
using the Kruskal-Wallis analysis of variance 
(ANOVA). Patients who underwent attempted limb 
salvage were compared with those who underwent 
primary amputation using the Mann-Whitney U 
(MW) test whilst proportions were analysed with a 
Chi-squared test. 
Results 
Limb salvage 
Limb salvage was attempted in 104 (69%) patients. 
However, revascularisation failed in 13, four of whom 
subsequently died. A further 21 patients who under- 
went attempted limb salvage died giving a mortality 
at I year in these patients of 24%. Limb salvage proved 
successful in 70 patients (67% of patients in whom it 
was attempted) which represented 47% of patients in 
the study. 
Mortality 
The overall mortality was 27%. There was no sig- 
nificant difference in mortality between the groups 
(Chi-squared =1.318;df = 4;p = 0.859). 
Costs 
Median management costs over 12 months for each 
treatment group are provided in Table 3. The overall 
Group Median age (iq range) years  Male:female % Diabetes 
Revascularisation acute ischaemia (RAI) 
Angioplasty critical ischaemia (ACI) 
Reconstruction critical ischaemia (RCI) 
Primary unilateral mputation (UA) 
Bilateral mputees (BA) 
71 (65-81) 0.9:1 17 
75 (65-80) 1.5:1 31 
72 (66-78) 1.4:1 23 
68 (64-73) 2.8:1 44 
69 (53-74) 5.0:1 50 
Overall 71 (65.78) 1.6:1 30.7 
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Table 3. Median costs (interquartile range) 
Group Mortality/% IP Stay/Days IP Costs/£ OP Costs/£ Total Costs/£ 
RAI 21.7 23 (13-32) 3799 (2302-5416) 117 (0-491) 3970 (2984-5511) 
ACI 27.6 34 (11-46) 5064 (2282-7023) 1646 (39-2176) 6611 (3630-10200) 
RCI 23.1 28 (17-51) 5167 (3728-8576) 391 (116-1633) 6766 (4337-9677) 
UA 32.4 53 (42-71) 7963 (6475--10001) 1981 (0-3813) 10162 (7894-13026) 
BA 33.3 72 (29-128) 11220 (4723-18056) 1990 (0-2622) 13848 (11440-18056) 
Overall 26.7 34 (19-59) 5747 (3799-8938) 780 (39-2627) 7303 (4314-11566) 
FR* 46.2 79 (56-86) 12402 (8413-13465) 2360 (04013) 12927 (11106-15293) 
*Sub-group of patients in whom attempted revascularisation failed. 
costs incurred in the first year following presentation 
of primary amputation were far greater than those of 
attempted salvage (including failures) in limb-threat- 
ening ischaemia (MW;Z = -5.502;p = 0.000). The greater 
proportion of these costs were incurred whilst the 
patient was in hospital and were related to duration of 
stay. The cost of attempted salvage in acutely ischae- 
mic limbs was significantly less than in chronic, 
critically ischaemic limbs (ANOVA; 
H = 42.123;p = 0.000). Whether patients with critically 
ischaemic limbs underwent attempted salvage by 
angioplasty or surgery made no significant difference 
to their management costs (MW;Z =-0.167;p =0.866). 
Salvage failure significantly increased management 
costs beyond those of primary amputation. 
Discussion 
Patients in this study were not randomly allocated to 
the respective treatment groups and analysis revealed 
patients who underwent primary amputation were 
younger and more likely to be male and diabetic when 
compared to those in whom salvage was attempted. 
This difference in patient demography may have 
contributed to part of the difference in managrnent 
costs but is unlikely to account for virtually doubling 
the median cost of managing a primary unilateral 
amputee as opposed to patients in whom salvage was 
attempted (including failures). 
The single largest contributor to cost was duration 
of inpatient stay which was frequently prolonged in 
these patients because of slow progress with rehabili- 
tation or delay in discharge because of inappropriate 
housing or inadequate support. Adequate community 
care funding and good liaison with community care 
are vital in order to avoid unnecessary discharge 
delay/costs. A reduction in inpatient costs could also 
be effected by shortening the time required for 
rehabilitation or transfer to a less expensive facility 
(than an acute vascular surgical ward) which provides 
the necessary rehabilitation care. 
The costs of managing patients with acutely ischae- 
mic limbs were found to be less than those of patients 
with chronic critically ischaemic limbs. This finding 
can be explained by the minimal rehabilitation 
requirements of patients with acutely ischaemic limbs 
whose inpatient stay was short when compared with 
that of patients with critically ischaemic limbs. Inter- 
estingly, there was no significant difference in the costs 
of managing patients with critically ischaemic limbs 
by angioplasty or surgery. This was probably due to 
the similar degree of ischaemia and tissue loss 
(comparable number of minor amputations in the two 
groups) suffered by these patients whose duration of 
inpatient stay and rehabilitation needs were 
comparable. 
Obtaining accurate stimates of cost for various 
facilities/services within the health service can be 
difficult as the cost of certain facilities such as 
inpatient stay can vary (depending on hospital occu- 
pancy rates). However, every effort has been made to 
obtain accurate stimates in order to limit bias. 
This study provides further evidence to support an 
aggressive revascularisation policy in limb-threat- 
ening ischaemia. However, the costs of salvage failure 
are significantly greater than primary amputation and 
these episodes need to be minimised to maintain the 
cost-effectiveness of attempted revascularisation. 
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